These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22050085)

  • 1. Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
    Jensen PC; Thiele S; Steen A; Elder A; Kolbeck R; Ghosh S; Frimurer TM; Rosenkilde MM
    Br J Pharmacol; 2012 May; 166(1):258-75. PubMed ID: 22050085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.
    Barington L; Rummel PC; Lückmann M; Pihl H; Larsen O; Daugvilaite V; Johnsen AH; Frimurer TM; Karlshøj S; Rosenkilde MM
    J Biol Chem; 2016 Jul; 291(31):16208-20. PubMed ID: 27226537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.
    Jensen PC; Nygaard R; Thiele S; Elder A; Zhu G; Kolbeck R; Ghosh S; Schwartz TW; Rosenkilde MM
    Mol Pharmacol; 2007 Aug; 72(2):327-40. PubMed ID: 17652183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.
    Rummel PC; Thiele S; Hansen LS; Petersen TP; Sparre-Ulrich AH; Ulven T; Rosenkilde MM
    Mol Pharmacol; 2013 Sep; 84(3):335-45. PubMed ID: 23765404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.
    Rummel PC; Arfelt KN; Baumann L; Jenkins TJ; Thiele S; Lüttichau HR; Johnsen A; Pease J; Ghosh S; Kolbeck R; Rosenkilde MM
    Br J Pharmacol; 2012 Nov; 167(6):1206-17. PubMed ID: 22708643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships and identification of optmized CC-chemokine receptor CCR1, 5, and 8 metal-ion chelators.
    Chalikiopoulos A; Thiele S; Malmgaard-Clausen M; Rydberg P; Isberg V; Ulven T; Frimurer TM; Rosenkilde MM; Gloriam DE
    J Chem Inf Model; 2013 Nov; 53(11):2863-73. PubMed ID: 24083637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
    Thiele S; Malmgaard-Clausen M; Engel-Andreasen J; Steen A; Rummel PC; Nielsen MC; Gloriam DE; Frimurer TM; Ulven T; Rosenkilde MM
    J Med Chem; 2012 Sep; 55(18):8164-77. PubMed ID: 22957890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 8. Activation mechanisms of chemokine receptors.
    Jensen PC; Rosenkilde MM
    Methods Enzymol; 2009; 461():171-90. PubMed ID: 19480919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.
    de Mendonça FL; da Fonseca PC; Phillips RM; Saldanha JW; Williams TJ; Pease JE
    J Biol Chem; 2005 Feb; 280(6):4808-16. PubMed ID: 15548526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists.
    Liu L; Doijen J; D'huys T; Verhaegen Y; Dehaen W; De Jonghe S; Schols D; Van Loy T
    Biochem Pharmacol; 2021 Jun; 188():114565. PubMed ID: 33872569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multistep continuous-flow synthesis in medicinal chemistry: discovery and preliminary structure-activity relationships of CCR8 ligands.
    Petersen TP; Mirsharghi S; Rummel PC; Thiele S; Rosenkilde MM; Ritzén A; Ulven T
    Chemistry; 2013 Jul; 19(28):9343-50. PubMed ID: 23716302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GluVII:06--a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors.
    Rosenkilde MM; Schwartz TW
    Curr Top Med Chem; 2006; 6(13):1319-33. PubMed ID: 16918451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through allosteric versus orthosteric binding.
    Jensen PC; Thiele S; Ulven T; Schwartz TW; Rosenkilde MM
    J Biol Chem; 2008 Aug; 283(34):23121-8. PubMed ID: 18559339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring a model of a chemokine receptor/ligand complex in an explicit membrane environment by molecular dynamics simulation: the human CCR1 receptor.
    Shahlaei M; Madadkar-Sobhani A; Fassihi A; Saghaie L
    J Chem Inf Model; 2011 Oct; 51(10):2717-30. PubMed ID: 21910472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8.
    Jiang S; Lin X; Wu L; Wang L; Wu Y; Xu Z; Xu F
    Sci Adv; 2024 Feb; 10(5):eadj7500. PubMed ID: 38306437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).
    Karlshøj S; Amarandi RM; Larsen O; Daugvilaite V; Steen A; Brvar M; Pui A; Frimurer TM; Ulven T; Rosenkilde MM
    J Biol Chem; 2016 Dec; 291(52):26860-26874. PubMed ID: 27834679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation.
    Vaidehi N; Schlyer S; Trabanino RJ; Floriano WB; Abrol R; Sharma S; Kochanny M; Koovakat S; Dunning L; Liang M; Fox JM; de Mendonça FL; Pease JE; Goddard WA; Horuk R
    J Biol Chem; 2006 Sep; 281(37):27613-20. PubMed ID: 16837468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
    Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
    J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.
    Onuffer J; McCarrick MA; Dunning L; Liang M; Rosser M; Wei GP; Ng H; Horuk R
    J Immunol; 2003 Feb; 170(4):1910-6. PubMed ID: 12574358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.